Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Ansager Statsautoriseret Fysioterapi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   0.0% 0.0% 8.2% 3.1% 2.5% 3.5% 18.4% 18.4%   Credit score (0-100)   0 0 30 54 62 52 8 8   Credit rating   N/A N/A BB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 703 1,012 1,108 1,139 0.0 0.0   EBITDA   0.0 0.0 230 497 440 304 0.0 0.0   EBIT   0.0 0.0 230 495 408 272 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 226.6 493.5 406.7 117.4 0.0 0.0   Net earnings   0.0 0.0 176.3 391.5 316.7 54.0 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 227 493 407 117 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 158 126 94.7 0.0 0.0   Shareholders equity total   0.0 0.0 216 533 499 254 63.5 63.5   Interest-bearing liabilities   0.0 0.0 0.0 162 79.9 320 0.0 0.0   Balance sheet total (assets)   0.0 0.0 317 883 740 702 63.5 63.5   Net Debt   0.0 0.0 -176 -0.7 -207 -46.2 -63.5 -63.5     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 703 1,012 1,108 1,139 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 43.8% 9.5% 2.8% -100.0% 0.0%   Employees   0 0 0 2 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 317 883 740 702 64 64   Balance sheet change%   0.0% 0.0% 0.0% 178.2% -16.2% -5.0% -91.0% 0.0%   Added value   0.0 0.0 230.0 497.3 410.2 303.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 156 -63 -63 -95 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 32.7% 49.0% 36.8% 23.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% 72.5% 82.5% 50.3% 38.9% 0.0% 0.0%   ROI %   0.0% 0.0% 106.4% 108.7% 64.0% 48.6% 0.0% 0.0%   ROE %   0.0% 0.0% 81.5% 104.5% 61.4% 14.3% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 68.1% 60.3% 67.5% 36.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% -76.4% -0.1% -47.2% -15.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 30.4% 16.0% 126.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 2.1% 1.1% 81.4% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 3.1 2.1 2.6 1.4 0.0 0.0   Current Ratio   0.0 0.0 3.1 2.1 2.6 1.4 0.0 0.0   Cash and cash equivalent   0.0 0.0 175.8 162.7 287.2 366.2 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 216.3 374.9 373.2 158.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 249 410 304 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 249 440 304 0 0   EBIT / employee   0 0 0 248 408 272 0 0   Net earnings / employee   0 0 0 196 317 54 0 0